{"id":"W2588484778","doi":"10.1093/ofid/ofw275","title":"Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection","year":2017,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cegep de Saint Jerome; University of Alberta","funders":"ViiV Healthcare; Gilead Sciences; Merck; Bristol-Myers Squibb","keywords":"Medicine; Clostridium difficile; Vancomycin; Clinical endpoint; Randomized controlled trial; Internal medicine; Diarrhea; Population; Confidence interval; Clinical trial; Incidence (geometry); Surgery; Antibiotics; Microbiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006962338,0.0006056367,0.003187785,0.0005548117,0.0005258758,0.0004630757,0.0006100381,0.0002518648,0.0006186573],"category_scores_gemma":[0.001480172,0.0004381143,0.0007937984,0.0003662161,0.0005434402,0.0007390957,0.0005570222,0.0005616,0.00003871536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004257961,"about_ca_system_score_gemma":0.001239645,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01953502,"about_ca_topic_score_gemma":0.002477074,"domain_scores_codex":[0.9959286,0.0003752957,0.001131886,0.0008517762,0.0009423731,0.0007701005],"domain_scores_gemma":[0.9956568,0.001007921,0.000988625,0.001524721,0.0003851281,0.0004367626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9094812,0.009678651,0.07435277,0.0001004392,0.001083433,0.0001414004,0.00006700554,0.00001868583,0.001259161,0.0001179149,0.0001993363,0.003499994],"study_design_scores_gemma":[0.9592714,0.003056345,0.01484804,0.0002942595,0.001094198,0.00001555551,0.00006276387,0.0001067198,0.0205059,0.000164622,0.0001333717,0.0004467843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9557595,0.0001449444,0.00002458024,0.000774424,0.0004243266,0.01954584,0.0002787753,0.00009296856,0.02295461],"genre_scores_gemma":[0.9945554,0.0002945809,0.00002077986,0.0001095002,0.0002174994,0.003752988,0.0003971814,0.00008650871,0.0005655314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05950474,"threshold_uncertainty_score":0.9998071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03637115396985657,"score_gpt":0.3535723883710001,"score_spread":0.3172012344011436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}